Orthopedics
Partner with BD to support your combination drug product development needs for orthopedics.
- Orthopedics
- Addressing Your Needs
Orthopedics
Worldwide, around 7% of adults suffer from osteoarthritis, a degenerative and progressive joint disorder that causes pain and disability.1
Hyaluronic acid helps maintain musculoskeletal system health,1 and intraarticular injection of hyaluronic acid may be effective in the management of osteoarthritis and other musculoskeletal conditions.1
However, the viscosity of hyaluronic acid impacts the injecting pressure exerted on the syringe.2 A 2018 international survey found that 33% of orthopedic surgeons experienced recurrence of leakage from syringes carrying hyaluronic acid.3
BD can support the delivery of
hyaluronic acid to osteoarthritic
patients
BD Hylok™ Glass Prefillable Syringe for Hyaluronic Acid is validated for intraarticular administration of viscous product4 and comes with a Luer Lock Adaptor (LLA) to support needle connection.5,6,7
BD Hylok™ Glass Prefillable Syringe for Hyaluronic Acid is specifically designed for the injection of hyaluronic acid.
By choosing the BD Hylok™ Glass Prefillable Syringe for Hyaluronic Acid, you will join the 26 worldwide pharmaceutical companies who work with us to improve the lives of patients across the globe.8
You will also benefit from the support of our expert teams,
helping get your product to market with:
-
Device selection advice.
-
Standardized processesand quality control.
-
Flexible and efficient manufacturing.
BD HylokTM Glass Prefillable Syringe for
Hyaluronic Acid
Work with BD to develop your hyaluronic acid product and benefit
from our 60 years of industry experience and our expert support teams
Explore our products
BD Hylok™ Glass Prefillable Syringe
BD Hylok™ Glass Prefillable Syringe for Hyaluronic acid intradermal, subcutaneous or intraarticular injections
BD Hylok™ Glass Prefillable Syringe
- Fabio Ramos Costa, et al. Intra-Articular Hyaluronic Acid in Osteoarthritis and Tendinopathies: Molecular and Clinical Approaches - Biomedicines 2023, 11(4), 1061.
- Monheit, G. D., & Coleman, K. M. (2006). Hyaluronic acid fillers - Dermatologic Therapy, Vol. 19, 2006, 141–150.
- Understand Dermatologists & Rheumatologists perception of HA PFS leakages and the value associated to a leakage/breakage free HA PFS. [Voice of Customer Research, n=170, Regions: US, EU, South Korea, and China]. Pont de Claix, FR: Becton Dickinson and Company; 2018.
- BDM, Pharmaceutical System – internal report - RMSR 0007-2014 n°01 - Rev 04 103.107.110GP-D Rev 02 – dec 2022
- BD Hylok™ Design verification results [Internal Report]. Pont-de-Claix, Becton Dickinson and Company, 2016.
- BD Hylok Human Factors study (Executive Summary) - Pont-de-Claix, FR: Becton Dickinson and Company; 2017. The human factors study was a monocentric, single session, randomized, simulated validation study conducted in July 2017 in New York City and Boston by FarmDesign Inc. The study included 15 nurses with experience providing Intra-Articular injections and 15 dermatologists with experience injecting patients with hyaluronic acid fillers for cosmetic purposes. For trained intended users as defined in the Human Factors evaluation.
- BD Hylok™ IV connectors and needles compatibility [Internal Report]. Pont-de-Claix, Becton Dickinson and Company, 2016
- BD Customers compared to Evaluate Pharma ranking FY2019